Ethocle Reports has published its latest Market Research Report on Cardiac Valve Repairs - Medical Devices Pipeline Assessment, 2016. Formulate significant competitor information, analysis, and insights to improve R&D strategies. Browse market data tables and figures.

1. Cardiac Valve Repairs - Medical DevicesPipeline Assessment,2016
Ethocle Reportshaspublished its latest MarketResearch Reporton Cardiac Valve Repairs - Medical
DevicesPipeline Assessment,2016. Formulatesignificantcompetitorinformation,analysis, and insights
to improveR&D strategies.Browsemarketdata tablesand figures.
PublishedOn: 01-Dec-2016 | Pages: 130
Summary
GlobalData's Medical Devicessectorreport,“CardiacValve Repairs - Medical DevicesPipeline
Assessment,2016" providesanoverview of CardiacValve Repairscurrentlyinpipelinestage.
The report providescomprehensiveinformationonthe pipeline productswithcomparative analysisof
the productsat variousstagesof development.The reportreviewsmajorplayersinvolvedinthe pipeline
productdevelopment.Italsoprovidesinformationaboutclinical trialsinprogress,whichincludestrial
phase,trial status,trial start and enddates,and,the numberof trialsfor the keyCardiacValve Repairs
pipelineproducts.
Thisreportis preparedusingdatasourcedfromin-house databases,secondaryandprimaryresearchby
GlobalData'steamof industryexperts.
*Note:Certainsectionsinthe reportmaybe removedoralteredbasedonthe availabilityandrelevance
of data inrelationtothe equipmenttype.
Click here to find out more about this report?
Scope
- Extensive coverage of the CardiacValve Repairsunderdevelopment
- The report reviewsdetailsof majorpipeline productswhichincludes,productdescription,licensing
and collaborationdetailsandotherdevelopmental activities

2. - The report reviewsthe majorplayersinvolvedinthe developmentof CardiacValve Repairsandlistall
theirpipeline projects
- The coverage of pipeline productsbasedonvariousstagesof developmentrangingfromEarly
DevelopmenttoApproved/Issuedstage
- The report provideskeyclinical trial dataof ongoingtrialsspecifictopipeline products
- Recentdevelopmentsinthe segment/industry
Get Free Sample Report
Click here for Discounts
Reasons to buy
The report enablesyouto -
- Formulate significantcompetitorinformation,analysis,andinsightstoimprove R&Dstrategies
- Identifyemergingplayerswithpotentiallystrongproductportfolioandcreate effective counter-
strategiestogaincompetitiveadvantage
- Identifyandunderstandimportantanddiversetypes of CardiacValve Repairsunderdevelopment
- Developmarket-entryandmarketexpansionstrategies
- Planmergersandacquisitionseffectivelybyidentifyingmajorplayerswiththe mostpromisingpipeline
- In-depthanalysisof the product’scurrentstage of development,territoryandestimatedlaunchdate
Table of Contents
1.1 Listof Tables6
1.2 Listof Figures10
2 Introduction11
2.1 CardiacValve RepairsOverview11
3 ProductsunderDevelopment12
3.1 CardiacValve Repairs - Pipeline ProductsbyStage of Development12
3.2 CardiacValve Repairs - Pipeline ProductsbySegment13

3. 3.3 CardiacValve Repairs - Pipeline ProductsbyTerritory14
3.4 CardiacValve Repairs - Pipeline ProductsbyRegulatoryPath15
3.5 CardiacValve Repairs - Pipeline Productsby EstimatedApproval Date 16
3.6 CardiacValve Repairs - OngoingClinical Trials17
4 CardiacValve Repairs - Pipeline ProductsunderDevelopmentbyCompanies18
4.1 CardiacValve RepairsCompanies - PipelineProductsbyStage of Development18
4.2 CardiacValve Repairs - Pipeline ProductsbyStage of Development20
5 CardiacValve RepairsCompaniesandProductOverview 22
5.1 4tech CardioIrelandLimitedCompanyOverview 22
5.1.1 4tech CardioIrelandLimitedPipelineProducts&OngoingClinicalTrialsOverview22
5.2 AdmedusLtdCompanyOverview24
5.2.1 AdmedusLtdPipeline Products&OngoingClinical TrialsOverview 24
5.3 AgamitMedical Ltd (Inactive) CompanyOverview 26
5.3.1 AgamitMedical Ltd (Inactive) Pipeline Products&OngoingClinical TrialsOverview 26
5.4 Ample Medical IncCompanyOverview 27
5.4.1 Ample Medical IncPipeline Products&OngoingClinical TrialsOverview 27
5.5 Ancora HeartInc CompanyOverview 28
5.5.1 Ancora HeartInc PipelineProducts&OngoingClinical TrialsOverview 28
5.6 ArborSurgical Technologies,Inc.CompanyOverview 30
5.6.1 Arbor Surgical Technologies,Inc.PipelineProducts&OngoingClinicalTrialsOverview30
5.7 BioStable Science &Engineering,Inc.CompanyOverview 31
5.7.1 BioStable Science &Engineering,Inc. PipelineProducts&OngoingClinicalTrialsOverview31
5.8 CardiosolutionsIncCompanyOverview 33
5.8.1 CardiosolutionsIncPipeline Products&OngoingClinical TrialsOverview33
5.9 Cardious,Inc.CompanyOverview34

4. 5.9.1 Cardious,Inc.Pipeline Products&OngoingClinical TrialsOverview 34
5.10 Children'sHospital BostonCompanyOverview 35
5.10.1 Children'sHospital BostonPipelineProducts&OngoingClinical TrialsOverview 35
5.11 CollPlantLtd.CompanyOverview38
5.11.1 CollPlantLtd.Pipeline Products&OngoingClinical TrialsOverview 38
5.12 coramaze technologiesGmbHCompanyOverview 39
5.12.1 coramaze technologiesGmbHPipelineProducts&OngoingClinicalTrialsOverview39
5.13 CoroneoInc.CompanyOverview40
5.13.1 CoroneoInc. Pipeline Products&OngoingClinical TrialsOverview 40
5.14 CUBE SRL CompanyOverview 41
5.14.1 CUBE SRL PipelineProducts&OngoingClinical TrialsOverview 41
5.15 Edwards LifesciencesCorpCompanyOverview 42
5.15.1 Edwards LifesciencesCorpPipeline Products& OngoingClinical TrialsOverview 42
5.16 Emory UniversityCompanyOverview 45
5.16.1 Emory UniversityPipeline Products&OngoingClinical TrialsOverview 45
5.17 Lartim Medical Ltd CompanyOverview47
5.17.1 Lartim Medical Ltd Pipeline Products&Ongoing Clinical TrialsOverview47
5.18 Mardil Medical,Inc.CompanyOverview48
5.18.1 Mardil Medical,Inc.Pipeline Products&OngoingClinical TrialsOverview48
5.19 Mayo ClinicUSCompanyOverview 50
5.19.1 Mayo ClinicUSPipelineProducts&OngoingClinical TrialsOverview 50
5.20 MedtentiaABCompanyOverview 51
5.20.1 MedtentiaABPipelineProducts&OngoingClinical TrialsOverview 51
5.21 MiCardia CorpCompanyOverview54
5.21.1 MiCardia CorpPipeline Products&OngoingClinical TrialsOverview 54

5. 5.22 MichiganCritical Care Consultants,Inc.CompanyOverview 56
5.22.1 Michigan Critical Care Consultants,Inc.Pipeline Products&OngoingClinical TrialsOverview56
5.23 Middle PeakMedical IncCompanyOverview 58
5.23.1 Middle PeakMedical IncPipelineProducts&OngoingClinical TrialsOverview 58
5.24 Millipede,LLCCompanyOverview59
5.24.1 Millipede,LLCPipeline Products&OngoingClinical TrialsOverview 59
5.25 Mitral Heal CompanyOverview 60
5.25.1 Mitral Heal PipelineProducts&OngoingClinical TrialsOverview 60
5.26 Mitralix Ltd. CompanyOverview61
5.26.1 Mitralix Ltd. Pipeline Products&OngoingClinical TrialsOverview 61
5.27 Mitre Medical Corp.CompanyOverview 62
5.27.1 Mitre Medical Corp.PipelineProducts&OngoingClinical TrialsOverview 62
5.28 NeochordInc CompanyOverview64
5.28.1 NeochordInc Pipeline Products&OngoingClinical TrialsOverview 64
5.29 North CarolinaState UniversityCompanyOverview68
5.29.1 North CarolinaState UniversityPipeline Products&OngoingClinical TrialsOverview 68
5.30 Phoenix CardiacDevices,Inc.CompanyOverview 69
5.30.1 Phoenix CardiacDevices,Inc.PipelineProducts&OngoingClinical TrialsOverview 69
5.31 QuantumCorInc. (Inactive) CompanyOverview 71
5.31.1 QuantumCorInc. (Inactive) Pipeline Products&OngoingClinical TrialsOverview 71
5.32 Rambam HealthCare CampusCompanyOverview 72
5.32.1 Rambam HealthCare CampusPipelineProducts&OngoingClinical TrialsOverview 72
5.33 ReCor Medical,Inc.CompanyOverview 73
5.33.1 ReCor Medical,Inc.Pipeline Products&OngoingClinical TrialsOverview 73
5.34 Sree ChitraTirunal Institute forMedical Sciences&TechnologyCompanyOverview 74

6. 5.34.1 Sree Chitra Tirunal Institute forMedical Sciences&TechnologyPipelineProducts&Ongoing
Clinical TrialsOverview 74
5.35 St. Jude Medical IncCompanyOverview 75
5.35.1 St. Jude Medical Inc Pipeline Products&OngoingClinical TrialsOverview 75
5.36 TransCardiac Therapeutics,LLCCompanyOverview 77
5.36.1 TransCardiac Therapeutics,LLCPipeline Products&OngoingClinical TrialsOverview 77
5.37 TrinityCollege DublinCompanyOverview 78
5.37.1 TrinityCollege DublinPipelineProducts&OngoingClinical TrialsOverview 78
5.38 Valcare Medical CompanyOverview79
5.38.1 Valcare Medical Pipeline Products&OngoingClinical TrialsOverview 79
5.39 ValtechCardioLtd CompanyOverview 81
5.39.1 ValtechCardioLtd Pipeline Products&OngoingClinical TrialsOverview 81
5.40 ViacorInc CompanyOverview88
5.40.1 Viacor Inc Pipeline Products&OngoingClinical TrialsOverview 88
6 CardiacValve Repairs- RecentDevelopments89
6.1 Nov26, 2016: EdwardsLifesciencestoAcquire ValtechCardioforUSD340 Million89
6.2 Nov22, 2016: MedtronicReportsSecondQuarterFinancial Results89
6.3 Nov16, 2016: MedtronicReleasesFY16IntegratedPerformanceReport92
6.4 Nov15, 2016: CEVA to workwithMedtronicfor distributionfacilityconstruction92
6.5 Nov09, 2016: FirstPatientTreatedinU.S.RandomizedTrial of NeoChord’s,Off-Pump,Minimally
Invasive RepairforDegenerative Mitral Regurgitation93
6.6 Nov08, 2016: CorindusVascularRoboticsReportsThirdQuarter2016 Results94
6.7 Nov07, 2016: DexteraSurgical ReportsFiscal 2017 FirstQuarterFinancial Results95
6.8 Oct 31, 2016: GuidedDeliverySystemsAnnouncesSeniorLeadersandCompanyName Change to
Ancora Heart96
6.9 Oct 28, 2016: NeoChordPasses500 PatientTreatmentMilestone 97
6.10 Oct 28, 2016: 4Tech ElectsEx-MedtronicCEOWilliam(“Bill”) A.HawkinsasitsChairman97

7. 6.11 Oct 25, 2016: Edwards LifesciencesReportsThirdQuarterResults98
6.12 Oct 20, 2016: CorindusVascularRoboticsAppointsJeff LemasterChief CommercialOfficer100
6.13 Oct 19, 2016: St. Jude Medical ReportsThirdQuarter2016 Results100
6.14 Oct 11, 2016: BioStable Science &EngineeringCompletesDirectDe NovoApplicationtoFDA forthe
HAART 300 AorticAnnuloplastyDevice 101
6.15 Sep16, 2016: World’sfirstTranscatheterTricuspidValve Repair(TTVR) hasbeensuccessfully
achievedwithoutuse of TEE and General Anesthesiainfeasibilitystudyof 4TechTriCinchat SanRaffaele
Hospital,Milan,Italy102
6.16 Sep16, 2016: ValtechCardioPresents:CardiobandTricuspidSuccessfulFirstinMan Casesand2-
Year CardiobandMitral Data at PCR LondonValves2016 103
6.17 Sep15, 2016: MedtronicNamesMark Ploof SeniorVice Presidentof Global Operationsand
BusinessServices104
6.18 Aug 25, 2016: MedtronicReportsFirstQuarterFinancial Results104
6.19 Aug 09, 2016: DexteraSurgical ReportsFY2016 FourthQuarterFinancial Results107
6.20 Aug 04, 2016: CorindusVascularRoboticsReportsSecondQuarter2016 Results108
6.21 Jul 26, 2016: Edwards LifesciencesReportsSecondQuarterResults109
6.22 Jul 20, 2016: St. Jude Medical ReportsSecondQuarter2016 Results111
6.23 Jun 30, 2016: NuVasiveAgreestoSettlePatentLitigationWithMedtronic112
6.24 Jun 29, 2016: DexteraSurgical AppointsMarkSobermanM.D.,Leaderin Thoracic Surgery,as
Medical Director113
6.25 Jun 20, 2016: Valcare Medical,anAccelmedPortfolioCompany,AnnouncesSuccessfulFirst-In-
Human Proceduresof the AmendCatheterDeliveredAnnuloplastyRing113
6.26 Jun 20, 2016: CardicaChangesCompanyName toDexteraSurgical 114
6.27 Jun 15, 2016: TranscatheterTricuspidValve Repair(TTVR) Has BeenSuccessfullyAchievedin
FeasibilityStudyof 4TechTriCinchat SanRaffaele Hospital,Milan,Italy115
6.28 Jun 06, 2016: MedtronicOutlinesFutureGrowthVisionatInvestorDay115
6.29 May 31, 2016: MedtronicReportsFourthQuarterand Fiscal Year 2016 Financial Results116
6.30 May 16, 2016: BioStable Science&EngineeringInitiatesEuropeanCommercializationof the HAART
300 AorticAnnuloplastyDevice118

8. 6.31 May 16, 2016: 4Tech and Dr. Jean-ClaudeLaborde enterintopartnershiptoaccelerate 4TechR&D
and clinical development119
6.32 May 16, 2016: OtsukaInvestsinReCorMedical 120
6.33 May 13, 2016: NeoChordReceivesFDA ApprovaltobeginClinical Trial forTreatmentof
DegenerativeMitral Valve Regurgitation120
6.34 May 12, 2016: ReCorMedical RaisesUSD10 MillioninVenture Financing120
6.35 Apr 08, 2016: AdmedusExpandsDistributionAgreementWithCoroneo120
6.36 Apr 08, 2016: AdmedusExtendsDistributionAgreementwithCoroneo121
6.37 Mar 29, 2016: DavidH. Adams,MD and Michael A.Borger,MD, PhDto Serve as National Principal
InvestigatorsforNeoChord’sU.S.Pivotal Trial 121
6.38 Mar 09, 2016: LivaNovaReceivesRegulatoryApproval inCanadaforitsInnovative Memo3D
ReChordAnnuloplastyRingforMitral Valve Repair122
6.39 Mar 09, 2016: 4Tech RaisesUSD29 MillioninSeriesBFinancing122
6.40 Mar 08, 2016: BioStable Science &EngineeringAnnouncesCEMark Approval ForThe HAART 300
AorticAnnuloplastyDevice 122
6.41 Feb10, 2016: NeoChordAgainAwardedNUBStatus1 in Germany123
6.42 Feb09, 2016: ValtechCardiobandReconstructionSystemforMitral Valve RepairReceives
ReimbursementinGermany123
6.43 Feb02, 2016: Edwards LifesciencesReportsFourthQuarterResults124
6.44 Jan 27, 2016: AdmedusEntersintoDistributionAgreementwithCoroneo125
6.45 Jan 27, 2016: AdmedusSignsExclusive DistributionAgreementWithCoroneo125
7 Appendix127
7.1 Methodology127
7.2 AboutGlobalData130
7.3 Contact Us 130
7.4 Disclaimer130